Home > Boards > Free Zone > Penny Fundamentals > $heriff SRV''s House of Blues and Rockin'' picks!

The ARYC OvaDx® ovarian cancer test will set the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
PennyStock Alert Member Profile
Member Level 
Followed By 530
Posts 38,207
Boards Moderated 6
Alias Born 04/26/12
160x600 placeholder
PennyStock Alert Member Level  Thursday, 04/25/19 10:05:53 PM
Re: None
Post # of 45943 
The ARYC OvaDx® ovarian cancer test will set the standard for early detection and pre-symptomatic screening utilizing a microarray based diagnostic test. We expect to expand this menu of tests to provide other early detection tests for key diseases where adequate diagnostic screening tests do not exist and where early detection can save lives and improve quality of life, such as Parkinson’s disease, Alzheimer’s disease, prostate cancer, and other diseases and medical conditions. We expect that other cancer tests, neurological assays, and areas such as allergy and food intolerance testing will benefit from the efficient patient screening model that are utilized in our tests. Additional markets for consideration that will also benefit from screening tests using our licensed technology are blood typing, parentage testing, forensics, human leukocyte antigen (HLA) analysis, infectious disease diagnosis, food testing, crop testing, and anti-terrorism analysis.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist